RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00044881.xml

CC BY-NC-ND 4.0 · J Lab Physicians 2017; 9(01): 067-068
DOI: 10.4103/0974-2727.187923
DOI: 10.4103/0974-2727.187923
Letters to Editor
Establishing Syva Methotrexate Assay on Siemens Dimension RxL Analyzer: Experience in a Tertiary Cancer Care Laboratory
Financial support and sponsorship Nil.
Publikationsverlauf
Artikel online veröffentlicht:
19. Februar 2020
© 2017.
Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India
-
REFERENCES
- 1 Oellerich M, Engelhardt P, Schaadt M, Diehl V. Determination of methotrexate in serum by a rapid, fully mechanized enzyme immunoassay (EMIT). J Clin Chem Clin Biochem 1980;18:169-74.
- 2 Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, et al. Harrison’s Principles of Internal Medicine. 17th ed., Ch. 81. USA: The McGraw-Hill Companies, Inc.; 2008.
- 3 Borgman MP, Hiemer MF, Molinelli AR, Ritchie JC, Jortani SA. Improved sensitivity for methotrexate analysis using enzyme multiplied immunoassay technique on the Siemens Viva-E instrument. Ther Drug Monit 2012;34:193-7.
- 4 Wilson JF, Tsanaclis LM, Barnett K. External quality assessment of Syva Emit and Abbott TDx II assays for methotrexate in serum. Ther Drug Monit 1996;18:721-3.
- 5 Suh-Lailam BB, Juenke JM, Thompson CD, Johnson-Davis KL. Performance Characteristics of Three Assays for the Therapeutic Drug Monitoring of Methotrexate. Abstract Presentation, Thirteenth International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, USA; September, 2013.